Maxcyte (MXCT) Non-Current Debt (2020)
Maxcyte's (MXCT) quarterly Non-Current Debt came in at $4.9 million in Q4 2020.
Powered by 
Analysis
Maxcyte (MXCT) Non-Current Debt (2020) Analysis & Trends
Maxcyte (MXCT) has reported Non-Current Debt for 1 consecutive years, with $4.9 million the latest figure, recorded in Q4 2020.
- On a quarterly basis, Non-Current Debt changed N/A year-over-year to $4.9 million in Q4 2020; TTM through Dec 2020 was $4.9 million, a N/A change from a year earlier, with the FY2020 full-year figure at $4.9 million, changed N/A from the prior year.
- Non-Current Debt was $4.9 million for Q4 2020 at Maxcyte.
- Over five years, Non-Current Debt peaked at $4.9 million in Q4 2020 and troughed at $4.9 million in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | 42.28 Bn |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | 26.56 Bn |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | 3.65 Bn |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | 1.49 Bn |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | 2.63 Bn |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | 200.00 Mn |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | 1.20 Bn |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | 551.05 Mn |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | - |
| 10 | Maxcyte | 131.93 Mn | 131.93 Mn | 5.60 Mn | - |